# Vitamin B1 Cognition Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/vitamin-b1-cognition-randomized-trial-evidence-review
Category: evidence-review
Summary: Vitamin B1 Cognition Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are s
Last reviewed: 2026-07-09
Reviewed by: Migaku Evidence Review
# Vitamin B1 Cognition Randomized Trial: What the Evidence Says

## Quick Answer

Vitamin B1 Cognition Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Nutritional supplements and cognition in healthy aging and mild cognitive impairment patients: a systematic review and network meta-analysis | systematic review | 1 | 2026-05-01 | 10.1016/j.tjpad.2026.100518 |
| Diet and Microbiota–Gut–Brain Axis: A Novel Nutritional Therapy | research article | 4 | 2026-04-14 | 10.3390/nu18081223 |

## What The Sources Report

- Concurrently, the number of individuals affected by dementia is anticipated to nearly triple by 2050, with associated treatment costs projected to reach US$2.8 trillion by 2030. [Liu Xing (2026); evidence level 1]
- In addition, omega-3 fatty acids support synaptic plasticity and exert anti-inflammatory effects; however, evidence is mixed, as randomized trials in healthy older adults show limited benefits, while several analyses report modest improvements in aged or MCI patients. [Liu Xing (2026); evidence level 1]
- Recent evidence shows that trillions of microorganisms in the gastrointestinal tract (GI tract) act as active regulators of various metabolic functions, including but not limited to neurologic function, mood, sleep quality, cognitive performance, and pain perception. [Markonda Lakshmi (2026); evidence level 4]
- Psychobiotics (probiotics and prebiotics) that confer mental health benefits through intestinal microbiota modulation represent a particularly promising therapeutic category, with preliminary evidence that suggests utility across depression, anxiety, cognitive impairment, and other psychiatric conditions. [Markonda Lakshmi (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For vitamin b1 cognition randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Liu Xing (2026). Nutritional supplements and cognition in healthy aging and mild cognitive impairment patients: a systematic review and network meta-analysis. DOI: 10.1016/j.tjpad.2026.100518. PMCID: PMC12966656. PMID: 41764841. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12966656/
- Markonda Lakshmi (2026). Diet and Microbiota–Gut–Brain Axis: A Novel Nutritional Therapy. DOI: 10.3390/nu18081223. PMCID: PMC13118773. PMID: 42075036. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13118773/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.